Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Diabetes Treatment Devices Market From 2025 to 2029?

In recent times, there has been a significant expansion in the market for diabetes treatment devices. Its size is projected to increase from $11.61 billion in 2024 to $12.34 billion in 2025, displaying a compound annual growth rate (CAGR) of 6.3%. The growth observed in the historical period is credited to the heightened prevalence of diabetes, enhanced understanding of diabetes management, increased use of insulin delivery devices, higher healthcare spending in developing nations, and an upsurge in the availability of sophisticated glucose monitoring systems.

In the forthcoming years, the diabetes treatment devices market is likely to witness significant expansion. The market is projected to reach a value of $15.61 billion in 2029, progressing at a compound annual growth rate (CAGR) of 6.1%. This growth during the predicted timeline could be driven by factors such as an increased demand for wearable and non-invasive monitoring gadgets, a rising emphasis on individualized diabetes care, broader adoption of digital health platforms and applications, augmented demand for remote diabetes management services, and growing government initiatives supporting diabetes control programs. The trending factors anticipated during this timeframe include advancements in continuous glucose monitoring technology, refined insulin delivery systems with artificial intelligence incorporation, the creation of smart wearable diabetes gadgets, innovation in non-invasive blood sugar monitoring, and the implementation of voice assistants in device functionality.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25750&type=smp

What Elements Are Contributing To Growth In The Diabetes Treatment Devices Market?

The rise in obesity rates is anticipated to fuel the expansion of the market for diabetes treatment devices moving ahead. The obesity rate is a measure of the proportion of people deemed obese according to their body mass index (BMI). Unhealthy diets rich in calories, sugars, and fats, which can result in significant weight gain if not counteracted by physical exercise, are largely contributing to the rise in obesity rates. Devices used for diabetes treatment aid in lowering obesity rates by fostering improved blood sugar regulation, thus promoting healthier lifestyle choices and weight management. For instance, as per the Centers for Disease Control and Prevention, a government agency based in the US, in 2022, 22 American states noted an adult obesity rate of 35% or more, an increase from 19 states in 2021. Therefore, this surge in obesity rates is stimulating the expansion of the market for diabetes treatment devices.

Which Segments Are Detailed In The Global Diabetes Treatment Devices Market Report?

The diabetes treatment devices market covered in this report is segmented –

1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels

3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users

Subsegments:

1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices

2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices

3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters

4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips

5) By Lancets: Standard Lancets, Safety Lancets

6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices

7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors

8) By Transmitters: Reusable Transmitters, Disposable Transmitters

9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers

10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches

Which Emerging Trends And Strategic Shifts Are Shaping The Diabetes Treatment Devices Market?

Leading companies in the diabetes treatment devices market are prioritizing the creation of innovative solutions like hybrid closed-loop insulin pump systems. These systems enhance glycemic control and simplify diabetes management for patients. Hybrid closed-loop insulin pump systems are sophisticated diabetes devices that self-regulate insulin delivery based on continuous glucose monitoring (CGM) data. However, they still need users to manually enter their insulin doses during mealtime. For example, in March 2022, Medtronic PLC, a medical device corporation based in Ireland, introduced the MiniMed 780G system. This system, equipped with SmartGuard technology, is dedicated to managing type 1 diabetes in individuals from 7 to 80 years of age. The advanced system self-adjusts basal insulin and administers correction boluses every five minutes. This helps to sustain glucose levels within a personal target range and corrects for missed meal boluses or discrepancies in carbohydrate computation. The system also comes with Meal Detection technology, a fingerstick-free continuous glucose monitor, and an infusion set meant for up to a week’s use. These features can be accessed and controlled using a dedicated mobile application.

Who Are The Key Contributors To Growth In The Diabetes Treatment Devices Market?

Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Eli Lilly And Company, Novo Nordisk A/S, Becton, Dickinson And Company, Hoffmann-La Roche Ltd., Insulet Corporation, DexCom Inc., Tandem Diabetes Care Inc, Lifescan Inc., Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc., Bigfoot Biomedical Inc., Medtrum Technologies Inc., Diabeloop SA, Roche Diabetes Care GmbH

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/diabetes-treatment-devices-global-market-report

Which Region Is Projected To Lead The Diabetes Treatment Devices Market By 2025?

North America was the largest region in the diabetes treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25750&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model